ICN EXPERT MEMBERS
Robyn Tate is a Professor at the John Walsh Centre for Rehabilitation Research, Kolling Institute of Medical Research, located in the Sydney Medical School at the University of Sydney. Her background is in clinical and neuropsychology, and she has extensive clinical experience in the rehabilitation of traumatic brain injury. Robyn co-directed work to develop scales to assess the methodological quality of single-case research (the SCED Scale and the RoBiNT Scale), and led an international team in producing the SCRIBE 2016 reporting guidelines for single-case experimental designs in the behavioural sciences.
Patrick Onghena is a full professor at the KU Leuven, Faculty of Psychology and Educational Sciences in Leuven, Belgium. His background is in clinical psychology, research methodology, and statistics. He teaches courses to bachelor and master students in psychology and in educational sciences on descriptive and inferential statistics, and on quantitative, qualitative, and mixed methods. His main research interests include single-case experimental design and analysis, the methodology of systematic reviewing and meta-analysis, distribution-free statistical inference, mixed methods research, and research on statistics education. He is the author of numerous publications on these topics and an author of the handbook on Randomization Tests.
Nicholas J. Schork, is Deputy Director and Distinguished Professor of Quantitative Medicine at The Translational Genomics Research Institute (TGen) in Phoenix, AZ. Dr. Schork also has Adjunct Professorships at the City of Hope National Medical Center, the University of California San Diego and Scripps Research. He has published over 550 articles in many areas of biomedical and translational science, including patient-oriented clinical trials design. He also has a long history of collaborative and consortium-related research, including his current position as scientific director of the current NIA-funded Longevity Consortium, whose goals are to identify factors that contribute to human health and longevity.
Karina Davidson, As the head of the Center for Personalized Health at the Feinstein Institutes for Medical Research, Dr. Davidson focuses on innovations in N-of-1 trials for the personalization of chronic disease treatment and symptom management. Her past studies include randomized controlled trials on healthy and hypertensive patients, depression screening and treatments, psychosocial and behavioral risk exploration, and cardiac-incident recurrence and mortality.
Johan Vlaeyen, works at the Universities of Leuven (Belgium) and Maastricht (Netherlands). His main research interests/expertise are the behavioral, cognitive and motivational mechanisms underlying the transition from common acute aversive sensations (pain, fatigue, tinnitus) to chronic bodily symptoms and disability. Johan highly values translational research, and he and his team have developed customized cognitive-behavioral management strategies for individuals suffering chronic bodily symptoms and utilized replicated single-case experimental designs to evaluate the effects of these interventions.
Rikard Wicksell is a clinical researcher and psychologist at Karolinska University Hospital, and an Associate Professor in Psychology, and head of the research group Behavioral Medicine at the Department of Clinical Neuroscience, Karolinska Institutet. Since 2001 he has developed a treatment model and a clinical research program for adult and pediatric chronic pain patients based on ACT. His ongoing translational research program includes studies related to treatment evaluation (outcome and change processes), predictors and moderators of change, the role and function of biological processes in pain and behavioral treatment, measurement development, parental and family factors in pediatric chronic pain, e-health (computer and smartphone based assessment and treatment).
Michael Perdices is a neuropsychologist with more than 30 years clinical and research experience. For the last 20 years he has been a Senior Clinical Neuropsychologist at Royal North Shore Hospital, Sydney. Michael was a co-director of the work to develop the SCED Scale, the RoBiNT Scale and the SCRIBE 2016 reporting guidelines.